Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
How Does Earnings Affect Dyadic Dyai Stock Price At 0.89 Up 4.71 20260402 Bud Q4 2025 Earnings Anheuser Busch Inbev Sa Belgium Adr Beats Eps Estimates With 0.95 20260403 1 Is Scienjoy Sj Stock Good For Passive Investors Price At 1.23 Down 7.17 20260406 Is Ovintiv Ovv Stock Growing Now Price At 59.16 Down 0.04 20260406 What Happens To Crown Castle Cci Stock After Earnings Price At 84.91 Down 1.92 20260407 News Analysis Consumer sentiment declines to another new record low as Americans fret over Ira Is AMC Networks AMCX stock worth considering In Focus 20260418 Columbia STK Stock Market Risk 015 20260418 BBIO BridgeBio Pharma Inc posts wider than expected Q4 2025 loss sending shares down nearly 1 percent in todays session Ralliant Corporation RAL Bullish Thesis Underscored by Grid Modernization Tailwinds and Valuation Upside Kingstone Companies KINS Stock Is It a Strong Buy Kingstone Companies posts narrow EPS beat at 108 BlackRock Inc BLK Canadian Subsidiary Declares Final April 2026 Cash Distribution for iShares Premium Money Market ETF Maison Solutions MSS Stock Sell Signals Extends Gains 20260420 Centene Corporation CNC Health Nets 10M LA Affordable Housing Investment Delivers Dual Operational and Shareholder Value Humana Inc HUM Partners With Parsley Health to Expand InNetwork Access to Functional Medicine Nationwide What makes Marsh MRSH a compelling holding for the long term 130 20260508 Montauk Renewables MNTK Stock Volatility Q4 2025 EPS Misses Views What Archimedes ATIIW management focus reveals about priorities Overhead Buying 20260508 Is Tevogen TVGN stock showing weakness Q4 2025 Earnings Beat Estimates PeapackGladstone PGC Slides 108 as Selling Pressure Mounts 20260515 Sound SPMA Trading at 2508 Key Decision Point 20260515 Torrid CURV Falls 471 Watching 124 Support 20260515 What Net Worth Puts You in the Top 1 Insights on Building a FirstClass Portfolio What Taoping TAOPs 077 Decline Means for Investors 20260518 Should You Sell Prime Medicine PRME After 410 Drop 20260518 Nexalin Technology NXL Trading at 034 Key Decision Point 20260514 CEO Appointment Signals Commercial Expansion Push for Brenmiller Energys BNRG360 Strategy AMDs Expanding AI CPU Opportunity Signals New Growth Phase for the Chipmaker KnightSwift Transportation Faces Modest Decline Amid Sector Headwinds Eli Lilly Shares Rise Following Positive Obesity Drug Trial Results Afghanistans Economic Collapse Drives Desperate Acts Fathers Selling Children to Survive Berkshire Hathaway Reenters Airlines with 26 Billion Delta Air Lines Stake Professional Title Gold Prices Face Potential Selling Pressure as Market Priced for Rate Hikes Amid Stagflation Concerns Samsung Chip Workers Potential Bonus Reaches 432000 Average Under Tentative Strike Agreement Vincent Bollors Media Influence Sparks Debate Over Democracy and EU Intervention Markets Shift Toward Fed Rate Hike Expectations Following Strong Inflation Data Monte Rosa Therapeutics Inc GLUE Q1 2026 Earnings WiderthanExpected Loss Compounds Investor Caution WD Q1 2026 Earnings EPS Surges Past Estimates with 62 Surprise COCO Q1 2026 Earnings Major EPS Beat Drives Optimism Despite Stock Decline PDS Biotechnology Q1 2026 Earnings Narrowed Loss Per Share and Clinical Progress Drive Positive Market Response AWK Q1 2026 Earnings EPS Falls Short Shares Slip Slightly Veris Residential VRE Holds Steady Near 19 as Consolidation Persists Marchex Inc MCHX Holds Steady at 168 as Key Levels Come into Focus Nuveen Quality Municipal Income Fund NAD Gains 095 as YieldSeeking Investors Return BingEx FLX Edges Higher as Shares Test Key Resistance Near 237 PANW Q1 2026 Earnings Strong EPS Beat Amid Robust Cybersecurity Demand PEW Q1 2026 Earnings NarrowerThanExpected Loss Surprises Analysts urbangro Inc UGRO Q3 2025 Earnings Staggering Loss Shocks Market Amid Missing Revenue Data Kenvue Inc KVUE Q1 2026 Earnings Solid EPS Beat Drives Modest Share Uptick Edgewise Therapeutics Inc EWTX Q1 2026 Earnings Narrowerthanexpected loss underscores disciplined RD execution